Generated AI-informed Intervention (Emohaa) vs Group ACT vs WL on Emotional Distress
Comparing Generated AI (Emohaa) and Group ACT in Reducing Emotional Distress: a Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Emotional Distress, such as anxiety and depression, is an essential issue worldwide. There have been several evidence-based psychotherapies that are effective in improving emotional distress, such as Acceptance and Commitment Therapy (ACT). However, the scarcity of professionals and the imbalance in the distribution of mental health resources prevent individuals in need from accessing immediate and effective help. Artificial intelligence (AI) has the potential to promote this problem. The existing studies have provided preliminary support for the application of AI in mental health interventions. One such model, Emohaa, a generated AI model, has been examined for its effectiveness in adult emotional distress. However, despite the limited reliability of the single-group design, parallel randomized controlled trials are scarce to validate this finding further. This present study is to fill this gap. This study aims to examine the effectiveness of the generated AI (Emohaa) in reducing emotional distress, including anxiety and depression, compared with group ACT and waitlist. In this parallel randomized controlled trial, it is hypothesized that (1) Compared with the waitlist, Emohaa and group ACT could significantly improve participants' emotional distress, including anxiety and depression symptoms; (2) Emohaa would lead to a greater reduction in anxiety and depression symptoms compared with group ACT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2024
CompletedFirst Submitted
Initial submission to the registry
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2024
CompletedApril 25, 2025
September 1, 2024
3 months
December 6, 2024
April 24, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
Patient Health Questionnaire (PHQ-9)
PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
0, 2, 4, 6, 8, and 10 weeks
Generalized Anxiety Disorder (GAD-7)
GAD-7 is an easy-to-perform initial screening tool for generalized anxiety disorder. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
0, 2, 4, 6, 8, and 10 weeks
UCLA Loneliness Scale (ULS-3)
ULS-3 is a brief version of the UCLA Loneliness Scale with 3 items, which was designed to assess loneliness. Questions are scored on a Likert scale of 1-4 with 1 being never and 4 being always.
0, 2, 4, 6, 8, and 10 weeks
Self-Concept Clarity Scale (SCCS)
SCCS is a 12-item scale to measure the clarity of self-concept. Questions are scored on a Likert scale of 1-5 with 1 being strongly disagree and 5 being strongly agree.
0, 2, 4, 6, 8, and 10 weeks
Acceptance and Action Questionnaire-2nd Edition (AAQ-II)
AAQ-II is the second version of the Acceptance and Action Questionnaire with 7 items. Questions are scored on a Likert scale of 1-7 with 1 being never and 7 being always
0, 2, 4, 6, 8, and 10 weeks
Insomnia Severity Index (ISI)
ISI is a 7-item screening tool to measure the severity of sleep problems. Questions are scored on a 0-4 scale with different descriptions
0, 2, 4, 6, 8, and 10 weeks
Client Satisfaction Questionnaire (CSQ-8)
CSQ-8 is an easy-to-perform initial screening tool for client satisfaction with mental health services. Questions are scored on a Likert scale of 1-4 with 1 being low satisfaction and 4 being high satisfaction.
2, 4, 6, 8, and 10 weeks
Digital Working Alliance Inventory (DWAI)
DWAI is an 8-item scale to measure the working alliance between participants and the AI model revised by the Working Alliance Inventory. Questions are scored on a Likert scale of 1-7 with 1 being totally disagree and 7 being totally agree.
6, 8, and 10 weeks
Study Arms (3)
Generated AI (Emohaa)
EXPERIMENTALGroup ACT
ACTIVE COMPARATORWaitlist Group (WLG)
SHAM COMPARATORInterventions
Participants will complete the intervention process by interacting with the Wechat applet. Participants will be required to complete a 6-week self-help therapy. Participants will be required to have a 30-minute dialogue including input and reflection time with Emohaa each week simultaneously with group ACT. Participants are free to dialogue with Emohaa for the rest of the week. An independent research assistant will monitor the intervention process from the platform. If the corresponding dialogue is not completed on time each week, the participant will be reminded via WeChat to complete this session before the start of the next session in the following week.
A 6-week group ACT intervention. Each group has 6-10 participants. Each session is one hour.
During the intervention period, participants in the WLG were only required to complete the appropriate assessments without receiving any intervention. Upon completion of the 15-day follow-up assessment, participants in the WLG could be free to choose to receive one of the two interventions. The intervention will be the same as the corresponding experimental group.
Eligibility Criteria
You may qualify if:
- Adults with 18-25 ages;
- Suffering from emotional distress (PHQ-9 \> 9 or GAD-7 \> 9);
- Ability to use the mobile phone to interact with AI;
- Consent to participate in the study.
You may not qualify if:
- High risk of self-injury and suicide;
- Presence of psychotic symptoms (i.e., delusions);
- Serious substance use problems;
- Other mental or physical illnesses requiring urgent medical assistance;
- Received other psychological or pharmacological interventions in the last month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central University of Finance and Economics, China
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Private Investigator
Study Record Dates
First Submitted
December 6, 2024
First Posted
December 16, 2024
Study Start
September 20, 2024
Primary Completion
December 20, 2024
Study Completion
December 28, 2024
Last Updated
April 25, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
Personal contact in reliable reason